dc.contributor.author | Captur, G | en_US |
dc.contributor.author | Moon, JC | en_US |
dc.contributor.author | Topriceanu, C-C | en_US |
dc.contributor.author | Joy, G | en_US |
dc.contributor.author | Swadling, L | en_US |
dc.contributor.author | Hallqvist, J | en_US |
dc.contributor.author | Doykov, I | en_US |
dc.contributor.author | Patel, N | en_US |
dc.contributor.author | Spiewak, J | en_US |
dc.contributor.author | Baldwin, T | en_US |
dc.contributor.author | Hamblin, M | en_US |
dc.contributor.author | Menacho, K | en_US |
dc.contributor.author | Fontana, M | en_US |
dc.contributor.author | Treibel, TA | en_US |
dc.contributor.author | Manisty, C | en_US |
dc.contributor.author | O'Brien, B | en_US |
dc.contributor.author | Gibbons, JM | en_US |
dc.contributor.author | Pade, C | en_US |
dc.contributor.author | Brooks, T | en_US |
dc.contributor.author | Altmann, DM | en_US |
dc.contributor.author | Boyton, RJ | en_US |
dc.contributor.author | McKnight, A | en_US |
dc.contributor.author | Maini, MK | en_US |
dc.contributor.author | Noursadeghi, M | en_US |
dc.contributor.author | Mills, K | en_US |
dc.contributor.author | Heywood, WE | en_US |
dc.date.accessioned | 2023-05-16T12:39:10Z | |
dc.date.available | 2022-09-16 | en_US |
dc.date.issued | 2022 | en_US |
dc.identifier.issn | 2352-3964 | en_US |
dc.identifier.other | ARTN 104293 | |
dc.identifier.other | ARTN 104293 | |
dc.identifier.other | ARTN 104293 | en_US |
dc.identifier.other | ARTN 104293 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/87278 | |
dc.relation.ispartof | EBIOMEDICINE | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | COVID-19 | en_US |
dc.subject | Proteomics | en_US |
dc.subject | Post-acute sequelae of SARS-CoV-2 (PASC) | en_US |
dc.title | Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.ebiom.2022.104293 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000892269200004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 85 | en_US |
qmul.funder | The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Council | en_US |